Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) Peptide
-
- Target See all BCAR3 products
- BCAR3 (Breast Cancer Anti-Estrogen Resistance 3 (BCAR3))
- Origin
- Human, Cow
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Characteristics
- The peptide is used to block Anti-BCAR3 Antibody reactivity.
-
-
- Application Notes
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Buffer
- Lyophilized powder
- Storage
- -20 °C
- Storage Comment
- Shipped at 4°C. Store at -20°C for one year.
- Expiry Date
- 12 months
-
- Target
- BCAR3 (Breast Cancer Anti-Estrogen Resistance 3 (BCAR3))
- Synonyms
- NSP2 Peptide, SH2D3B Peptide, AI131758 Peptide, AND-34 Peptide, BCAR3 Peptide, breast cancer anti-estrogen resistance 3 Peptide, breast cancer anti-estrogen resistance 3 L homeolog Peptide, BCAR3 Peptide, Bcar3 Peptide, bcar3 Peptide, bcar3.L Peptide
- Background
- NSP2, SH2D3B, Breast cancer anti-estrogen resistance protein 3, Novel SH2-containing protein 2, SH2 domain-containing protein 3B
- Gene ID
- 8412
- UniProt
- O75815
-